In both blood and hematoma fluid, inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-6 and IL-10 raise, and the anti-inflammatory activities in the hematoma may play a role in the risk of a recurrence of CSDH [3]. Here, IL6 is linked to hematoma.